Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Helgason

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|August 15, 2013
Mutational analysis of Polycomb genes in solid tumours identifies PHC3 amplification as a possible cancer-driving genetic alterationF Crea, L Sun, L Pikor, et al.
Nature Immunology|July 31, 2001
Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene productS Latour, G Gish, C D Helgason, et al.
The EMBO Journal|December 19, 1998
Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cellsM Huber, C D Helgason, M P Scheid, et al.
Blood|February 15, 1997
Impaired steel factor responsiveness differentially affects the detection and long-term maintenance of fetal liver hematopoietic stem cells in vivoC L Miller, V I Rebel, C D Helgason, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 1998
The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulationM Huber, C D Helgason, J E Damen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1990
Development of precytotoxic T cells in cyclosporine-suppressed mixed lymphocyte reactionsJ W Hooton, C L Miller, C D Helgason, et al.
Immunity|February 7, 2001
The RasGAP-binding protein p62dok is a mediator of inhibitory FcgammaRIIB signals in B cellsI Tamir, J C Stolpa, C D Helgason, et al.
Molecular Immunology|June 1, 1993
Induction of a proteoglycan core protein mRNA in mouse T lymphocytesJ F Elliott, C L Miller, B Pohajdak, et al.
Experimental Hematology|February 1, 1996
Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cellsC L Miller, V I Rebel, M E Lemieux, et al.
Blood|March 15, 1997
Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesisH J Lawrence, C D Helgason, G Sauvageau, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|August 15, 2013
Mutational analysis of Polycomb genes in solid tumours identifies PHC3 amplification as a possible cancer-driving genetic alterationF Crea, L Sun, L Pikor, et al.
Nature Immunology|July 31, 2001
Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene productS Latour, G Gish, C D Helgason, et al.
The EMBO Journal|December 19, 1998
Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cellsM Huber, C D Helgason, M P Scheid, et al.
Blood|February 15, 1997
Impaired steel factor responsiveness differentially affects the detection and long-term maintenance of fetal liver hematopoietic stem cells in vivoC L Miller, V I Rebel, C D Helgason, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 1998
The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulationM Huber, C D Helgason, J E Damen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1990
Development of precytotoxic T cells in cyclosporine-suppressed mixed lymphocyte reactionsJ W Hooton, C L Miller, C D Helgason, et al.
Immunity|February 7, 2001
The RasGAP-binding protein p62dok is a mediator of inhibitory FcgammaRIIB signals in B cellsI Tamir, J C Stolpa, C D Helgason, et al.
Molecular Immunology|June 1, 1993
Induction of a proteoglycan core protein mRNA in mouse T lymphocytesJ F Elliott, C L Miller, B Pohajdak, et al.
Experimental Hematology|February 1, 1996
Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cellsC L Miller, V I Rebel, M E Lemieux, et al.
Blood|March 15, 1997
Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesisH J Lawrence, C D Helgason, G Sauvageau, et al.
Pageof 4